Literature DB >> 8851686

The cause of maintained hypercalciuria after the surgical cure of primary hyperparathyroidism is a defect in renal calcium reabsorption.

M L Farias1, A G Delgado, D Rosenthal, J G Vieira, T Kasamatsu, M J Lazarevitch, M F Pereira, M B Lima.   

Abstract

The hypercalciuria that eventually remains after the successful removal of a solitary parathyroid adenoma may originate from excessive intestinal calcium absorption, bone resorption or deficient renal reabsorption. In order to clarify this question, ten patients surgically cured from primary hyperparathyroidism (PHPx), ten age-matched normal subjects and five nephrolithiasic patients with renal hypercalciuria (RH) were studied after five days on a low calcium diet, either during fasting or after oral calcium load. Fasting serum calcium, amino-terminal and intact PTH levels and also urinary cAMP excretion were normal in every individual patient. Serum ionized calcium and inulin clearance (GFR) were used for calculations of the filtered load (FL Ca) and the fractional excretion of calcium (FE Ca). Six PHPx patients displayed fasting calciuria above the upper limit calculated for control subjects, despite having the lowest GFR and FL Ca (p < 0.05 vs control). These patients (h-PHPx) had a small calciuric response to oral calcium load. Serum 1,25-(OH)2D3 and 25OHD3 did not correlate with calciuria. Our findings exclude intestinal hyperabsorption and excessive bone resorption in h-PHPx patients, and strongly suggest a renal tubular defect in calcium reabsorption as the cause of their hypercalciuria. This defect could be primary, as in RH, but only three hPHPx patients had recurrent kidney stones before surgery. On the other hand, as a negative correlation between GFR and FE Ca was only found in PHPx patients, it seems probable that the disturbances in glomerular and tubular functions were secondary to the long standing hypercalcemic hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851686     DOI: 10.1007/BF03347852

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  38 in total

1.  Idiopathic hypercaicuria.

Authors:  P H HENNEMAN; P H BENEDICT; A P FORBES; H R DUDLEY
Journal:  N Engl J Med       Date:  1958-10-23       Impact factor: 91.245

2.  The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.

Authors:  R A Kaplan; M R Haussler; L J Deftos; H Bone; C Y Pak
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

3.  Primary hyperparathyroidism (PHP) revisited.

Authors:  C R Kleeman; S Salehmoghaddam; G Hertz
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

Review 4.  Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient?

Authors:  C R Kleeman; K Norris; J W Coburn
Journal:  Miner Electrolyte Metab       Date:  1987

5.  Osteomalacia as a very late manifestation of primary hyperparathyroidism.

Authors:  F S Kaplan; S R Soffer; M D Fallon; J G Haddad; M Dalinka; E C Raffensperger
Journal:  Clin Orthop Relat Res       Date:  1988-03       Impact factor: 4.176

6.  A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism.

Authors:  C Y Pak; M J Nicar; R Peterson; J E Zerwekh; W Snyder
Journal:  J Clin Endocrinol Metab       Date:  1981-09       Impact factor: 5.958

7.  Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism.

Authors:  G L Irvin; D J Newell; S D Morgan
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

8.  The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism.

Authors:  A E Broadus; R L Horst; R Lang; E T Littledike; H Rasmussen
Journal:  N Engl J Med       Date:  1980-02-21       Impact factor: 91.245

9.  Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis?

Authors:  A D'Angelo; M G Lodetti; S Giannini; R Castrignano; M al Awady; L Malvasi; A Fabris; G Maschio
Journal:  Miner Electrolyte Metab       Date:  1992

10.  Evidence for a direct action of cholecalciferol and 25-hydroxycholecalciferol on the renal transport of phosphate, sodium, and calcium.

Authors:  J B Puschett; J Moranz; W S Kurnick
Journal:  J Clin Invest       Date:  1972-02       Impact factor: 14.808

View more
  3 in total

1.  Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades.

Authors:  Marcio L Griebeler; Ann E Kearns; Euijung Ryu; Prabin Thapa; Matthew A Hathcock; L Joseph Melton; Robert A Wermers
Journal:  J Clin Endocrinol Metab       Date:  2016-01-11       Impact factor: 5.958

2.  Persistence of hypercalciuria after successful surgical treatment for primary hyperparathyroidism.

Authors:  Francisco Rodolfo Spivacow; Armando Luis Negri; Elisa Elena del Valle; Erich Fradinger; Carolina Martinez; Ana Polonsky
Journal:  Int Urol Nephrol       Date:  2011-04-20       Impact factor: 2.370

3.  Icariin attenuates glucocorticoid-induced bone deteriorations, hypocalcemia and hypercalciuria in mice.

Authors:  Jing Zhang; Jia Song; Jiang Shao
Journal:  Int J Clin Exp Med       Date:  2015-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.